http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112662755-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2021-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112662755-B |
| titleOfInvention | Diagnosis marker for preeclampsia and application of diagnosis marker in preparation of target spot medicine |
| abstract | The invention provides a diagnosis marker for preeclampsia and application thereof in preparation of a target drug, belonging to the technical field of biomedicine and cell biology. The invention finds that the expression level of LINC01962 in the placental tissue of PE patients is obviously reduced. Meanwhile, the invention discovers that the LINC01962 is overexpressed in human choriotrophoblast cells, so that the migration and invasion capacity of the trophoblast cells can be effectively promoted. |
| priorityDate | 2021-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.